Bay of Plenty advanced breast cancer survivors are marching on Wellington today , fighting for more time.
Hundreds, if not thousands, of people diagnosed with incurable cancer - and their supporters - will present a petition to Parliament, calling for better access to life-prolonging drugs Ibrance and Kadcyla.
Ibrance, the brand name for palbociclib, and Kadcyla, also known as T-DM1 or trastuzumab emtansine, are already in use and funded or subsidised in other OECD counties such as Australia and the United Kingdom. The drugs, considered to be "game changers", cost a person $6000 or $10,000 a month respectively.
The group includes Tauranga woman Tracy Barr-Smith, who travelled down yesterday.
Barr-Smith said having the ability to afford the treatment meant "everything to people in my situation".